Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Marilyn N. Martinez, Leposava Antonovic, Michael Court, Mauro Dacasto, Johanna Fink-Gremmels, Butch Kukanich, Chuck Locuson, Katrina Mealey, Michael J. Myers & Lauren Trepanier. (2013) Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics. Drug Metabolism Reviews 45:2, pages 218-230.
Read now
Read now
B. L. Hay Kraus, D. J. Greenblatt, K. Venkatakrishnan & M. H. Court. (2000) Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences. Xenobiotica 30:6, pages 575-588.
Read now
Read now
Y. NISHIBE, M. WAKABAYASHI, T. HARAUCHI & K. OHNO. (1998) Characterization of cytochrome P450 (CYP3A12) induction by rifampicin in dog liver. Xenobiotica 28:6, pages 549-557.
Read now
Read now
E. TANAKA, C. NARISAWA, H. NAKAMURA, Y. SAWA, H. ETOH, K. TADANO, T. HORIE, H. OHKAWA & S. MISAWA. (1998) Changes in the enzymatic activities of beagle liver during maturation as assessed both in vitro and in vivo. Xenobiotica 28:8, pages 795-802.
Read now
Read now
Articles from other publishers (30)
Michael H. Court, Katrina L. Mealey, Neal S. Burke, Tania Perez Jimenez, Zhaohui Zhu & Joseph J. Wakshlag. (2023) Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug–drug interactions involving canine cytochrome P‐450, UDP‐glucuronosyltransferase, and P‐glycoprotein. Journal of Veterinary Pharmacology and Therapeutics.
Crossref
Crossref
Daniela Schneider, Dirk Bier, Marcus Holschbach, Andreas Bauer & Bernd Neumaier. (2021) Species Differences in Microsomal Metabolism of Xanthine-Derived A1 Adenosine Receptor Ligands. Pharmaceuticals 14:3, pages 277.
Crossref
Crossref
Stephanie E. Martinez, Jian Shi, Hao-Jie Zhu, Tania E. Perez Jimenez, Zhaohui Zhu & Michael H. Court. (2019) Absolute Quantitation of Drug-Metabolizing Cytochrome P450 Enzymes and Accessory Proteins in Dog Liver Microsomes Using Label-Free Standard-Free Analysis Reveals Interbreed Variability. Drug Metabolism and Disposition 47:11, pages 1314-1324.
Crossref
Crossref
S. Achanta & L. K. Maxwell. (2016) Reaction phenotyping of vinblastine metabolism in dogs. Veterinary and Comparative Oncology 14:2, pages 161-169.
Crossref
Crossref
C. W. Locuson, P. Williams, J. M. Adcock & J. S. Daniels. (2016) Evaluation of tizanidine as a marker of canine CYP1A2 activity. Journal of Veterinary Pharmacology and Therapeutics 39:2, pages 122-130.
Crossref
Crossref
V Simerdova, I Hajek & P Schanilec. (2015) Addisonian crisis in a dog treated with phenobarbitone. Australian Veterinary Journal 93:4, pages 105-108.
Crossref
Crossref
Aki T. Heikkinen, Arno Friedlein, Mariette Matondo, Oliver J. D. Hatley, Aleksanteri Petsalo, Risto Juvonen, Aleksandra Galetin, Amin Rostami-Hodjegan, Ruedi Aebersold, Jens Lamerz, Tom Dunkley, Paul Cutler & Neil Parrott. (2014) Quantitative ADME Proteomics – CYP and UGT Enzymes in the Beagle Dog Liver and Intestine. Pharmaceutical Research 32:1, pages 74-90.
Crossref
Crossref
Stephanie Haller, Franz Schuler, Stanley E. Lazic, Dalila Bachir-Cherif, Stefanie D. Krämer, Neil J. Parrott, Guido Steiner & Sara Belli. (2012) Expression Profiles of Metabolic Enzymes and Drug Transporters in the Liver and along the Intestine of Beagle Dogs. Drug Metabolism and Disposition 40:8, pages 1603-1611.
Crossref
Crossref
Alexander V. LyubimovLin Xu, Biplab Das & Chandra Prakash. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
35
.
Lone D. Mössner, Andrea Schmitz, Regula Theurillat, Wolfgang Thormann & Meike Mevissen. (2011) Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans. American Journal of Veterinary Research 72:11, pages 1505-1513.
Crossref
Crossref
Beth Miskimins Mills, Matthew J. Zaya, Rodney R. Walters, Kenneth L. Feenstra, Julie A. White, Jason Gagne & Charles W. Locuson. (2010) Current Cytochrome P450 Phenotyping Methods Applied to Metabolic Drug-Drug Interaction Prediction in Dogs. Drug Metabolism and Disposition 38:3, pages 396-404.
Crossref
Crossref
M. T. BARATTA, M. J. ZAYA, J. A. WHITE & C. W. LOCUSON. (2010) Canine CYP2B11 metabolizes and is inhibited by anesthetic agents often co-administered in dogs. Journal of Veterinary Pharmacology and Therapeutics 33:1, pages 50-55.
Crossref
Crossref
K. Fukunaga, M. Saito, E. Matsuo, M. Muto, K. Mishima, M. Fujiwara & K. Orito. (2009) Long-lasting enhancement of CYP activity after discontinuation of repeated administration of phenobarbital in dogs. Research in Veterinary Science 87:3, pages 455-457.
Crossref
Crossref
Charles W. Locuson, Brian T. Ethell, Michael Voice, David Lee & Kenneth L. Feenstra. (2009)
Evaluation of
Escherichia coli
Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 Reductase
. Drug Metabolism and Disposition 37:3, pages 457-461.
Crossref
Crossref
Johanna Fink-Gremmels. (2008) Implications of hepatic cytochrome P450-related biotransformation processes in veterinary sciences. European Journal of Pharmacology 585:2-3, pages 502-509.
Crossref
Crossref
Hiroshi Komura & Masahiro Iwaki. (2008) Species Differences in In Vitro and In Vivo Small Intestinal Metabolism of CYP3A Substrates. Journal of Pharmaceutical Sciences 97:5, pages 1775-1800.
Crossref
Crossref
Alison Betts, Fidelma Atkinson, Iain Gardner, David Fox, Rob Webster, Kevin Beaumont & Paul Morgan. (2007)
Impact of Physicochemical and Structural Properties on the Pharmacokinetics of a Series of α1
L
-Adrenoceptor Antagonists
. Drug Metabolism and Disposition 35:8, pages 1435-1445.
Crossref
Crossref
H. Kamimura. (2006) Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations. Archives of Toxicology 80:11, pages 732-738.
Crossref
Crossref
Lauren A. Trepanier. (2006) Cytochrome P450 and Its Role in Veterinary Drug Interactions. Veterinary Clinics of North America: Small Animal Practice 36:5, pages 975-985.
Crossref
Crossref
Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues & Thomas H. Rushmore. (2003) SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450. Drug Metabolism and Disposition 31:9, pages 1161-1169.
Crossref
Crossref
Moshe Tom, C.R Myers & Michael R Waterman. (2002) Evaluating molar CYP1A level in fish hepatic microsomes by competitive ELISA using recombinant membrane-free CYP1A standard protein. Aquatic Toxicology 59:1-2, pages 101-114.
Crossref
Crossref
T. HOJO, R. OHNO, M. SHIMODA & E. KOKUE. (2002) Enzyme and plasma protein induction by multiple oral administrations of phenobarbital at a therapeutic dosage regimen in dogs. Journal of Veterinary Pharmacology and Therapeutics 25:2, pages 121-127.
Crossref
Crossref
Ryotaro Azuma, Masahito Komuro, Yasuro Kawaguchi, Kazuho Okudaira, Masahiro Hayashi & Hiroshi Kiwada. (2002) Comparative Analysis of In Vitro and In Vivo Pharmacokinetic Parameters Related to Individual Variability of GTS-21 in Canine. Drug Metabolism and Pharmacokinetics 17:1, pages 75-82.
Crossref
Crossref
Takashi Matsubara. (2002) Safety Evaluation and Drug Development based on Biological Fate of Drugs —Efforts Made to Overcome Drug Interaction in Drug Development—. Drug Metabolism and Pharmacokinetics 17:5, pages 379-394.
Crossref
Crossref
D.E Amacher, S.J Schomaker & J.E Burkhardt. (2001) The relationship among microsomal enzyme induction, liver weight and histological change in beagle dog toxicology studies. Food and Chemical Toxicology 39:8, pages 817-825.
Crossref
Crossref
K Walton, J.L Dorne & A.G Renwick. (2001) Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates. Food and Chemical Toxicology 39:7, pages 667-680.
Crossref
Crossref
Yoshimasa Kyokawa, Yasuhiro Nishibe, Mitsuko Wakabayashi, Toshio Harauchi, Toshiyuki Maruyama, Takahiko Baba & Kouji Ohno. (2001) Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs. Chemico-Biological Interactions 134:3, pages 291-305.
Crossref
Crossref
John E. Snawder & John C. Lipscomb. (2000) Interindividual Variance of Cytochrome P450 Forms in Human Hepatic Microsomes: Correlation of Individual Forms with Xenobiotic Metabolism and Implications in Risk Assessment. Regulatory Toxicology and Pharmacology 32:2, pages 200-209.
Crossref
Crossref
M.Teresa Donato, José V Castell & M.José Gómez-Lechón. (1999) Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. Journal of Hepatology 31:3, pages 542-549.
Crossref
Crossref
J.R Fry, D Sinclair, C.Holly Piper, S.-L Townsend & N.W Thomas. (1999) Depression of glutathione content, elevation of CYP2E1-dependent activation, and the principal determinant of the fasting-mediated enhancement of 1,3-dichloro-2-propanol hepatotoxicity in the rat. Food and Chemical Toxicology 37:4, pages 351-355.
Crossref
Crossref